v3.25.1
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash flows from operating activities:      
Net loss $ (2,303,587) $ (3,134,262)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 37,189 587,234  
Increase (decrease) in cash resulting from changes in:      
Prepaid expenses and other current assets 86,579 94,424  
Accounts payable 102,064 (43,482)  
Accrued and other current liabilities 143,689 (208,368)  
Total adjustments to reconcile net loss to net cash used in operations 369,521 429,808  
Net cash used in operating activities (1,934,066) (2,704,454) $ (11,100,000)
Cash flows from financing activities:      
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs 8,541,282  
Proceeds from exercise of pre-funded warrants 977  
Payment of prior period issuance costs (50,495)  
Net cash provided by financing activities 8,491,764  
Net increase (decrease) in Cash and cash equivalents 6,557,698 (2,704,454)  
Cash and cash equivalents at beginning of period 3,161,570 7,438,135 7,438,135
Cash and cash equivalents at end of period 9,719,268 4,733,681 $ 3,161,570
Non-cash financing activities:      
Issuance of abeyance shares (18)  
January 2025 PIPE issuance costs in accounts payable 79,102  
March 2025 Warrant Inducement issuance costs in accounts payable $ 456,631    

Source